Jiangsu Sihuan Bioengineering Co., Ltd
SZSE:000518.SZ
Overview | Financials
| Company Name | Jiangsu Sihuan Bioengineering Co., Ltd |
| Symbol | 000518.SZ |
| Currency | CNY |
| Price | 2.75 |
| Market Cap | 2,831,290,000 |
| Dividend Yield | 0% |
| 52-week-range | 2.43 - 3.72 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Yu Guo |
| Website | https://www.000518shsw.com/shsw |
An error occurred while fetching data.
About Jiangsu Sihuan Bioengineering Co., Ltd
Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers Drewson, an anti-tumor biotherapeutic drug for the treatment of renal cancer, malignant melanoma, and cancerous thoracic and peritoneal effusion; and Xinde Lusheng for the treatment of kidney cancer, melanoma, lung cancer, gastric cancer, malignant lymphoma, breast
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD








